(Q40795960)

23 September 2017

1 reference

title

Intravenous heparin dosing: patterns and variations in internists' practices (English)

1 reference

23 September 2017

B M Reilly

1

1 reference

23 September 2017

R Raschke

series ordinal

2

1 reference

23 September 2017

S Srinivas

series ordinal

3

1 reference

23 September 2017

T Nieman

series ordinal

4

1 reference

23 September 2017

publication date

1 October 1993

1 reference

Journal of General Internal Medicine

23 September 2017

published in

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

10

1 reference

23 September 2017

page(s)

536-542

1 reference

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

23 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02599634

Heparin kinetics determined by three assay methods

21 January 2018

1 reference

12 December 2020

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

1 reference

12 December 2020

Guidelines to control heparin treatment

1 reference

12 December 2020

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

1 reference

12 December 2020

The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits

1 reference

12 December 2020

Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant therapy

1 reference

12 December 2020

Heparin kinetics in venous thrombosis and pulmonary embolism

1 reference

12 December 2020

A Standard Heparin Nomogram for the Management of Heparin Therapy

1 reference

12 December 2020

The elimination from plasma of intravenous heparin. An experimental study on dogs and humans

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Management of heparin therapy: Controlled prospective trial

1 reference

12 December 2020

Physician practices in the treatment of pulmonary embolism and deep venous thrombosis

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease

1 reference

12 December 2020

Control and complications of intermittent heparin therapy

1 reference

12 December 2020

Antithrombotic agents in coronary artery disease

1 reference

12 December 2020

Audit of control of heparin treatment

1 reference

12 December 2020

Heparin in the treatment of venous thrombo-embolic disease: administration, control and results

1 reference

12 December 2020

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

12 December 2020

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

12 December 2020

Clinical use of the heparin nomogram

1 reference

12 December 2020

Optimal Therapeutic Level of Heparin Therapy in Patients With Venous Thrombosis

1 reference

12 December 2020

Kinetics of intravenously administered heparin in normal humans

1 reference

12 December 2020

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

12 December 2020

Assessment of Anticoagulant Treatment of Venous Thromboembolism

1 reference

12 December 2020

Heparin therapy for deep venous thrombosis

1 reference

12 December 2020

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

12 December 2020

Heparin therapy: a randomized prospective study

1 reference

12 December 2020

Non-biological factors in day to day variation of heparin requirements

1 reference

12 December 2020

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

1 reference

12 December 2020

Heparin therapy for thromboembolic disorders. A prospective evaluation of 134 cases monitored by the activated coagulation time

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

12 December 2020

Circadian changes in anticoagulant effect of heparin infused at a constant rate

1 reference

12 December 2020

Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis

1 reference

12 December 2020

Venous thromboembolism

1 reference

12 December 2020

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

1 reference

12 December 2020

Sources of error in heparin therapy of thromboembolic disease

1 reference

12 December 2020

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599634

1 reference

Dimensions Publication ID

23 September 2017

1034510630

0 references

1 reference